Oppenheimer & Co’s Axogen AXGN Stock Holding History

Oppenheimer & Co’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,095	Closed	-$156K	–	1558
2024 Q3	$156K	Buy	+11,095	New	+$123K	﹤0.01%	1433

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Oppenheimer & Co's AXGN Position: Q4 2024 in Review

Oppenheimer & Co sold out of Axogen (AXGN) in Q4 2024, closing a stake of 11,095 shares — an estimated $156K sold.

Oppenheimer & Co first reported a position in AXGN in Q3 2024 and held it in 1 quarter. The position peaked at $156K in Q3 2024. 172 funds tracked by Wall St. Rank hold AXGN as of Q4 2024.

Oppenheimer & Co reported no remaining Axogen position as of Q4 2024 after selling out during the quarter.
Oppenheimer & Co sold 11,095 Axogen shares in Q4 2024, an estimated $156K.
Oppenheimer & Co first reported a position in Axogen in Q3 2024 and held it in 1 quarter.
Oppenheimer & Co's Axogen position peaked at $156K in Q3 2024.
172 funds tracked by Wall St. Rank held Axogen as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.